Solid Tumor-Targeted Infiltrating Cytotoxic T Lymphocytes Retained by a Superantigen Fusion Protein Tumor-Targeting Cytotoxic T Lymphocytes
2011

Targeting Tumor-Immune Cells with a Fusion Protein

Sample size: 45 publication 10 minutes Evidence: high

Author Information

Author(s): Sun Jialin, Zhao Lina, Teng Lijie, Lin Feng, Zhang Hongna, Li Zhengnan, Gao Qiang

Primary Institution: Key Laboratory of Industrial Microbiology, Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, People's Republic of China

Hypothesis

Can a fusion protein of epidermal growth factor and staphylococcal enterotoxin effectively target and enhance the immune response against solid tumors?

Conclusion

The EGF-SEA fusion protein significantly inhibited the growth of solid tumors by enhancing the infiltration and activation of cytotoxic T lymphocytes.

Supporting Evidence

  • The EGF-SEA fusion protein significantly reduced tumor weight compared to control.
  • Increased levels of cytokines TNF-α and IFN-γ were observed in tumors treated with EGF-SEA.
  • The study demonstrated effective targeting of T lymphocytes to tumor sites using EGF-SEA.

Takeaway

Researchers created a special protein that helps immune cells find and attack tumors better, which could help treat cancer.

Methodology

Mice were injected with tumor cells and treated with either saline, SEA, or EGF-SEA, followed by tumor measurement and analysis of immune responses.

Limitations

The study was conducted in a mouse model, which may not fully replicate human responses.

Participant Demographics

Male ICR mice, 4-5 weeks old.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 0.54 to 1.37

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016642

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication